Fundraising Fox
Inocras
5 known investors
Find your way into Inocras
Inocras is a bioinformatics company that uses whole genome sequencing and proprietary analytics to produce clinically actionable insights for patient diagnosis and treatment, operating a CLIA-certified and CAP-accredited lab. It serves patients, clinicians, and researchers with whole genome diagnostic testing, sequencing and interpretation services, genetic counseling, and clinical trial matching.
Founders & leadership
Investors · 5
How we know: Dunamu & Partners's portfolio page · funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
Funding
SEC filings, press & company announcements$62M disclosed across 2 rounds · 2026
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Inocras do?
- Inocras is a bioinformatics company that uses whole genome sequencing and proprietary analytics to produce clinically actionable insights for patient diagnosis and treatment, operating a CLIA-certified and CAP-accredited lab. It serves patients, clinicians, and researchers with whole genome diagnostic testing, sequencing and interpretation services, genetic counseling, and clinical trial matching.
- Who founded Inocras?
- Inocras was founded by YoungSeok Ju.
- Who are Inocras's investors?
- Inocras's investors include Dunamu & Partners, Schmidt, DSC Investment, IMM Investment, Intervest.
- How much funding has Inocras raised?
- Inocras has disclosed $62M raised across 2 rounds.